Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandra Romano

Showing results (61-70 of 165) with videos related to

Pageof 17
Sort By:
Clinical Case Reports|April 11, 2020
Serum free light chains and multiple myeloma: Is it time to extend their application?Uros Markovic, Valerio Leotta, Daniele Tibullo, et al.
Cancers|February 24, 2024
Baseline IgM Amounts Can Identify Patients with Poor Outcomes: Results from a Real-Life Single-Center Study on Classical Hodgkin LymphomaAndrea Duminuco, Gabriella Santuccio, Annalisa Chiarenza, et al.
Hematology Reports|April 25, 2022
<i>Saprochete capitata</i>: Emerging Infections from Uncommon Microorganisms in Hematological DiseasesAndrea Duminuco, Calogero Vetro, Cinzia Maugeri, et al.
International Journal of Molecular Sciences|November 6, 2019
Monocytic Myeloid Derived Suppressor Cells in Hematological MalignanciesGiuseppe Alberto Palumbo, Nunziatina Laura Parrinello, Cesarina Giallongo, et al.
Plos One|July 12, 2014
Myeloid derived suppressor cells (MDSCs) are increased and exert immunosuppressive activity together with polymorphonuclear leukocytes (PMNs) in chronic myeloid leukemia patientsCesarina Giallongo, Nunziatina Parrinello, Daniele Tibullo, et al.
Frontiers in Oncology|January 7, 2021
Mitochondrial Bioenergetics at the Onset of Drug Resistance in Hematological Malignancies: An OverviewAlessandro Barbato, Grazia Scandura, Fabrizio Puglisi, et al.
British Journal of Haematology|November 8, 2014
Circulating myeloid-derived suppressor cells correlate with clinical outcome in Hodgkin Lymphoma patients treated up-front with a risk-adapted strategyAlessandra Romano, Nunziatina Laura Parrinello, Calogero Vetro, et al.
Frontiers in Oncology|June 9, 2015
Clinical Impact of the Immunome in Lymphoid Malignancies: The Role of Myeloid-Derived Suppressor CellsCalogero Vetro, Alessandra Romano, Flavia Ancora, et al.
British Journal of Haematology|February 16, 2019
Immune off-target effects of Brentuximab Vedotin in relapsed/refractory Hodgkin LymphomaAlessandra Romano, Nunziatina L Parrinello, Annalisa Chiarenza, et al.
Clinical Case Reports|September 30, 2021
The first description of a singular case of synchronous chronic myelomonocytic leukemia and diffuse large b-cell lymphomaAlessandra Romano, Michele Giusti, MaryAnn Di Giorgio, et al.
Pageof 17

Showing results (61-70 of 165) with videos related to

Sort By:
Pageof 17
Clinical Case Reports|April 11, 2020
Serum free light chains and multiple myeloma: Is it time to extend their application?Uros Markovic, Valerio Leotta, Daniele Tibullo, et al.
Cancers|February 24, 2024
Baseline IgM Amounts Can Identify Patients with Poor Outcomes: Results from a Real-Life Single-Center Study on Classical Hodgkin LymphomaAndrea Duminuco, Gabriella Santuccio, Annalisa Chiarenza, et al.
Hematology Reports|April 25, 2022
<i>Saprochete capitata</i>: Emerging Infections from Uncommon Microorganisms in Hematological DiseasesAndrea Duminuco, Calogero Vetro, Cinzia Maugeri, et al.
International Journal of Molecular Sciences|November 6, 2019
Monocytic Myeloid Derived Suppressor Cells in Hematological MalignanciesGiuseppe Alberto Palumbo, Nunziatina Laura Parrinello, Cesarina Giallongo, et al.
Plos One|July 12, 2014
Myeloid derived suppressor cells (MDSCs) are increased and exert immunosuppressive activity together with polymorphonuclear leukocytes (PMNs) in chronic myeloid leukemia patientsCesarina Giallongo, Nunziatina Parrinello, Daniele Tibullo, et al.
Frontiers in Oncology|January 7, 2021
Mitochondrial Bioenergetics at the Onset of Drug Resistance in Hematological Malignancies: An OverviewAlessandro Barbato, Grazia Scandura, Fabrizio Puglisi, et al.
British Journal of Haematology|November 8, 2014
Circulating myeloid-derived suppressor cells correlate with clinical outcome in Hodgkin Lymphoma patients treated up-front with a risk-adapted strategyAlessandra Romano, Nunziatina Laura Parrinello, Calogero Vetro, et al.
Frontiers in Oncology|June 9, 2015
Clinical Impact of the Immunome in Lymphoid Malignancies: The Role of Myeloid-Derived Suppressor CellsCalogero Vetro, Alessandra Romano, Flavia Ancora, et al.
British Journal of Haematology|February 16, 2019
Immune off-target effects of Brentuximab Vedotin in relapsed/refractory Hodgkin LymphomaAlessandra Romano, Nunziatina L Parrinello, Annalisa Chiarenza, et al.
Clinical Case Reports|September 30, 2021
The first description of a singular case of synchronous chronic myelomonocytic leukemia and diffuse large b-cell lymphomaAlessandra Romano, Michele Giusti, MaryAnn Di Giorgio, et al.
Pageof 17